A carregar...
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
BACKGROUND: According to the World Health Organization, glaucoma is a leading cause of irreversible blindness worldwide. By 2020, 80 million people will be affected by glaucoma in the world, which represents a significant financial burden to society. Glaucoma medications alone make up 38–52% of the...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924989/ https://ncbi.nlm.nih.gov/pubmed/31908505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S156558 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|